Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Genentech discovers new cytokine inducing apoptosis

Sep. 17, 1997

Pharmacia & Upjohn discovers potent camptothecin analogues

Sep. 17, 1997

Preliminary results from phase II/III Sensamide study

Sep. 16, 1997

NCI evaluates stability of SarCNU

Sep. 16, 1997

Cytel and Searle to collaborate on cancer therapies

Sep. 15, 1997

Oncologic Drugs Advisory Committee meets this week

Sep. 15, 1997

Matrix discontinues U.S. development of AccuSite

Sep. 15, 1997

Biricodar dicitrate enters phase II studies in ovarian cancer

Sep. 12, 1997

Clinical studies begin with BNP-7787

Sep. 12, 1997

Final phase I/IIa data reported on oral Panretin in APL

Sep. 11, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...